Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hillhouse Capital Related

560.395
+1.7660.32%
Number of Gainers:20
Number of Losers:32
Number of Flat:3
PE:- -
High:565.009
Open:558.132
Low:552.605
Close:558.629
Volume:760.82M
Turnover:28.06B
Market Cap:3.32T
Float Cap:2.50T

Loading ...

LUYE PHARMA (02186) Issues 52.92 Million Shares Due to Convertible Bond Conversion

Stock News
·
54 mins ago

Linxi County Market Supervision Bureau Conducts Special Inspection on Contact Lenses

Deep News
·
1 hour ago

iPhone 17 New Products to Launch Simultaneously on MEITUAN-W Flash Delivery Service

Deep News
·
1 hour ago

Zhejiang Orient Gene Biotech Co.,Ltd. (688298.SH) Subsidiary Obtains Medical Device Registration Certificates

Stock News
·
1 hour ago

Chengde Baiyou Business Co., Ltd. (Meituan Takeaway Chengde Store) Holds First Employee Representatives Congress

Deep News
·
1 hour ago

Haitong International Maintains "Outperform" Rating on HYGEIA HEALTH (06078) with Target Price of HKD 35.17

Stock News
·
1 hour ago

Beijing Strong Biotechnologies,Inc. (300406.SZ) Receives Two Medical Device Registration Certificates

Stock News
·
2 hours ago

Hong Kong Stocks Alert | FRONTAGE (01521) Surges Nearly 10% as Company's Profitability Reaches Key Turning Point with Q2 2025 Financial Performance Recovery

Stock News
·
3 hours ago

Qin Shuyao Investigates MEITUAN-W and Xiaohongshu: How "Instant Power + Content Seeding" is Reshaping Liquor Consumption

Deep News
·
3 hours ago

Property Management Companies Show Net Profit Recovery in H1 2025, High Dividend Yields Drive Valuation Enhancement

Stock News
·
4 hours ago

Hong Kong Stocks Movement | Property Management Stocks Rise with Real Estate Stocks as First-Tier Cities Implement Purchase Restriction Optimizations, Industry Shows Improved H1 Performance

Stock News
·
7 hours ago

Hong Kong Stocks Movement | Most Internet Healthcare Stocks Rise as National Medical Products Administration Regulates Online Prescription Drug Retail, Institutions Recommend Focusing on Industry Recovery Opportunities

Stock News
·
8 hours ago

Hong Kong Stocks Movement | JUNSHI BIO (01877) Surges Over 9% as JS005 Achieves Positive Results in Phase III Clinical Trial for Moderate to Severe Plaque Psoriasis

Stock News
·
8 hours ago

Hong Kong Stocks Movement | REMEGEN (09995) Surges Nearly 14% as Telitacicept's Marketing Application for Sjögren's Syndrome Treatment Accepted by CDE

Stock News
·
8 hours ago

Genscript Biotech (HKG:1548) Has A Pretty Healthy Balance Sheet

Simply Wall St.
·
11 hours ago

BRIEF-Simcere Pharmaceutical Group Says SIM0609 Obtains Clinical Trial Approval In China By NMPA

Reuters
·
Yesterday

Simcere Pharma Gets China Nod for Tumor Drug Trial

MT Newswires Live
·
Yesterday

TIGERMED to Hold First Extraordinary General Meeting of 2025 on September 29

Deep News
·
Yesterday

SIMCERE PHARMA (02096): SIM0609 (CDH17 Antibody-Drug Conjugate) Receives Clinical Trial Approval from National Medical Products Administration

Stock News
·
Yesterday

Simcere Pharmaceutical Group Announces Clinical Trial Approval for Innovative Anti-Tumor Drug SIM0609

Reuters
·
Yesterday